Publicacions en què col·labora amb LUIS HERMENEGILDO MARTIN ARIAS (39)

2023

  1. Hydroxychloroquine safety in Covid-19 vs non-Covid-19 patients: analysis of differences and potential interactions

    Expert Opinion on Drug Safety, Vol. 22, Núm. 1, pp. 71-79

2022

  1. Haplotypes in the GC, CYP2R1 and CYP24A1 Genes and Biomarkers of Bone Mineral Metabolism in Older Adults

    Nutrients, Vol. 14, Núm. 2

  2. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

  3. Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database

    Drugs - Real World Outcomes, Vol. 9, Núm. 2, pp. 211-218

2021

  1. A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 2, pp. 88-93

  2. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

  3. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 59, Núm. 4, pp. 280-288

2020

  1. Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases

    International Journal of Clinical Pharmacy, Vol. 42, Núm. 2, pp. 713-720

  2. Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.00860)

    Frontiers in Pharmacology

  3. Hydroxychloroquine and Potential Drug Interactions in Older Adults

    Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 679-681

  4. Kaposi sarcoma in patients on tumour necrosis factor alpha inhibitors: a case–noncase study

    Journal of the European Academy of Dermatology and Venereology

  5. Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study

    Frontiers in Pharmacology, Vol. 11

2019

  1. Guillain-barré syndrome and influenza vaccines: Current evidence

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 4, pp. 288-295

  2. Medicines under additional monitoring in the European Union

    Farmacia Hospitalaria, Vol. 43, Núm. 1, pp. 19-23

2018

  1. A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 56, Núm. 12, pp. 577-584

  2. Antipsychotics and cardiovascular risk: A case/non-case study

    Psychiatry Research, Vol. 270, pp. 341-347

  3. Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study

    International Journal of Clinical Pharmacy, Vol. 40, Núm. 4, pp. 928-935

2017

  1. Medication errors associated with oral administration of methotrexate. Data from spontaneous reporting and medical literature review

    Medicina Clinica, Vol. 148, Núm. 7, pp. 330-332

  2. Risk excess of mortality and use of antipsychotics: A case-noncase study

    International Clinical Psychopharmacology, Vol. 32, Núm. 1, pp. 1-5

  3. Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations

    Vaccine, Vol. 35, Núm. 37, pp. 4870-4876